Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy.

Slides:



Advertisements
Similar presentations
THOMAS F. LÜSCHER, M.D.  Mayo Clinic Proceedings 
Advertisements

Volume 89, Issue 3, Pages (March 2016)
When man turns to stone: Extraosseous calcification in uremic patients
Volume 89, Issue 3, Pages (March 2016)
Volume 75, Issue 12, Pages (June 2009)
Volume 85, Issue 2, Pages (January 2014)
Chronic kidney disease aggravates arteriovenous fistula damage in rats
Volume 83, Issue 3, Pages (March 2013)
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Jian-Hua Qiao, MD, Terence M. Doherty, BA, Michael C
The Case ∣ Acute renal failure and anemia
Oral bacteria in the occluded arteries of patients with Buerger disease  Takehisa Iwai, MD, PhD, Yoshinori Inoue, MD, PhD, Makoto Umeda, DDS, PhD, Yi Huang,
Does compliance mismatch alone cause neointimal hyperplasia?
Volume 58, Issue 1, Pages (July 2000)
A clinicopathologic study of immunoglobulin G4-related disease of the femoral and popliteal arteries in the spectrum of immunoglobulin G4-related periarteritis 
When man turns to stone: Extraosseous calcification in uremic patients
Cartilage MRI T2∗ relaxation time and perfusion changes of the knee in a 5/6 nephrectomy rat model of chronic kidney disease  C.-Y. Wang, Y.-J. Peng,
Renal artery stenosis and aneurysms associated with neurofibromatosis
Vein adaptation to arterialization in an experimental model
Volume 81, Issue 5, Pages (March 2012)
Superficial femoral artery thrombosis as a cause for distal embolism in primary antiphospholipid syndrome  Lannery S. Lauvao, MD, Kaoru R. Goshima, MD,
Volume 57, Issue 2, Pages (October 2000)
Volume 85, Issue 3, Pages (March 2014)
Volume 61, Issue 2, Pages (February 2002)
Vascular calcification is dependent on plasma levels of pyrophosphate
Thrombosis with outflow obstruction delays thrombolysis and results in chronic wall thickening of rat veins  Klaus See-Tho, MD, E.John Harris, MD  Journal.
The Case | Hypertension and neuropathy after travel
Conformational stress and anastomotic hyperplasia
Marie Claire Gubler, Corinne Antignac  Kidney International 
J.-S. Chiu, J.-E. Tzeng, Y.-F. Wang
Volume 74, Issue 1, Pages (July 2008)
Bret A. Mettler, MD, Virna L. Sales, MD, Chaz L
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions  Michael Madigan, MD, Fateh Entabi, MD, Brian Zuckerbraun, MD,
Volume 63, Issue 5, Pages (May 2003)
Volume 83, Issue 3, Pages (March 2013)
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 74, Issue 10, Pages (November 2008)
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Glenn C. Hunter, MD, Stephen H. Smyth, MD, Marie L. Aguirre, MD, B
Tao Lin, Catherine Horsfield, Michael G. Robson  Kidney International 
Neil J. Paloian, Elizabeth M. Leaf, Cecilia M. Giachelli 
Structure, not just function
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
James M. Wong, MDa, Michelle A
Volume 63, Issue 1, Pages (January 2003)
Volume 74, Issue 6, Pages (September 2008)
Yehuda G. Wolf, MD, Lars M. Rasmussen, MD, Yoav Sherman, MD, Warner P
Volume 84, Issue 2, Pages (August 2013)
Intraabdominal hemorrhage as a result of segmental mediolytic arteritis of an omental artery: Case report  Dianne M. Heritz, MD *, Jagdish Butany, MD,
Volume 59, Issue 6, Pages (June 2001)
The initiation and progression of sickle cell nephropathy
Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.
Immunosuppressive treatment of aortic allografts
Acute phosphate nephropathy
Patrick J. O'Hara, M. D. , Norman B. Ratliff, M. D. , Robert A
Human saphenous vein allograft bypass grafts: Immune response
The vascular secret of Klotho
Volume 87, Issue 1, Pages (January 2015)
Kirk J. Maurer, Robert P. Marini, James G. Fox, Arlin B. Rogers 
Volume 74, Issue 5, Pages (September 2008)
Richard L. Binns, MD  Journal of Vascular Surgery 
Volume 76, Issue 1, Pages (July 2009)
Quiz Page January 2010 American Journal of Kidney Diseases
Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy.
Volume 87, Issue 6, Pages (June 2015)
Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis  Valdeci da Cunha, PhD, Baby Martin-McNulty,
(A and B) Coronary intima plaque with subtle calcification in hematoxylin and eosin (H&E) stain (A) and Kossa stain (B). (A and B) Coronary intima plaque.
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Presentation transcript:

Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy L. Adams  Kidney International  Volume 85, Issue 3, Pages 668-676 (March 2014) DOI: 10.1038/ki.2013.351 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Patterns of calcification in breast arteries shown by von Kossa staining. (a) Diffuse punctate staining in the medial layer (patient 17). L indicates lumen. (b) Linear calcification of the internal elastic lamina (IEL) in patient 1. There is no intimal thickening. (c) Both diffuse medial and linear IEL calcification in the same artery (patient 12). Intimal thickening is present. (d) Severe confluent calcification (patient 1). (e) Two adjacent arteries with and without calcification (patient 8). (f) Calcification of small arteries and arterioles (patient 8). Bar=100μm in all images. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Histology of smooth muscle cells in calcified arteries. (a) Hematoxylin and eosin staining of a heavily calcified artery from patient 1 showing normal-appearing smooth muscle cells. (b) Staining for SM22α in the same artery. There was fracturing of the artery during sectioning. (c) Ductal epithelial cells do not stain for SM22α, whereas underlying smooth muscle is positive. (d) Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of a large, heavily calcified artery from patient 18 demonstrating no apoptosis adjacent to the calcifications (C). There is some staining of cells in the adventitia (arrows) and some artifactual staining of the calcifications. Most of the calcification was lost during sectioning. L indicates the lumen. (e) The von Kossa staining pattern corresponding to the region shown in d. (f) Positive TUNEL staining of neointimal cells. Bars=100μm. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Immunohistochemical analysis of matched sections of small breast arteries from two patients. (a) There is calcification within the media and of the internal elastic lamina (von Kossa staining). (b) All cells within the media stained for SM22α. There was no staining for osteocalcin (c) or Runx2 (d). Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Immunohistochemical analysis of matched sections of a large breast artery from patient 12. Left hand column: low magnification; bars=100μm. Right hand column: higher magnification of region indicated by box. (a) The von Kossa staining. (b) SM22α. (c) Osteocalcin. (d) Runx2. Bars=100μm. There is no staining for osteocalcin or Runx2. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Staining for osteogenic/chondrogenic markers. (a) Staining for osteocalcin in patient 17 showing a granular pattern within the media and in the internal elastic lamina. (b) Osteocalcin staining of heavy calcifications in patient 18. The vessel wall has fractured during sectioning. (c) The von Kossa staining of artery from patient 13. (d) Osterix immunostaining of the same artery. (e) The von Kossa staining of artery from patient 12. (f) SOX-9 immunostaining of the same artery. Bars=100μm. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Positive controls for immunohistochemical analysis. (a) Sample of bone showing cellular staining of the osteocytes for osteocalcin. (b) Runx2 staining of placenta. (c) Osterix immunostaining of neonatal mouse spine. (d) SOX-9 immunostaining of neonatal mouse spine. Bars=100μm. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Osteogenic markers in calcified arteries from lower extremities. Arrows indicate the internal elastic lamina with the intima (I) to the right, the media (M) to the left, and the adventitia (A) to the far left. (a) Decalcified section of a tibial artery showing staining for osteocalcin of the medial calcifications and some smooth muscle cells within the calcifications. (b) Section of a tibial artery showing no staining for osteocalcin. The artery fractured at the calcifications during sectioning, with loss of the intima. (c) Decalcified section of a tibial artery showing no staining for Runx2. The intima was lost due to a fracture at the internal elastic lamina during sectioning. (d) Decalcified section of a femoral artery from a patient with chronic kidney disease showing no staining for osterix. Bars=100μm. Kidney International 2014 85, 668-676DOI: (10.1038/ki.2013.351) Copyright © 2014 International Society of Nephrology Terms and Conditions